Found 3 matching trials
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189 in Healthy Adults 18 to 30 Years of Age
PHASE1The main objective of this trial is to evaluate the safety and immunogenici...
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults
PHASE1The main objective of Part A of this trial is to evaluate the safety and re...
Status
Active Not Recruiting
Location
Medical Affiliated Research Institute
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants
PHASE1The purpose of this study is to evaluate the safety and reactogenicity of m...
Status
Active Not Recruiting
Location
Pinnacle Research Group, LLC